Scholarlink

Purpose of Review <p>to describe the positive impact of timely diagnosis and treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) on the symptoms of severe asthma in patients with both diseases in the context of Latin America based on available prevalence data in the region and to describe the diagnosis and treatment strategy currently employed.</p> Recent Findings <p>it is estimated that prevalence of CRSwNP in patients with severe asthma in Latin America is comparable to the data presented at global level. The impact on patients’ health is comparable to those patients with other chronic diseases with greater recognition (asthma, Typer 2 Diabetes, rheumatoid arthritis). Despite socioeconomic differences, the diagnosis and treatment strategies employed in these Latin American patients is comparable to those in Europe or the United States.</p> Summary <p> In Latin America it is estimated that the prevalence of patients with severe asthma and CRSwNP is comparable to the data presented globally. Patients with severe asthma and CRSwNP present a more severe disease with lower chances of therapeutic success despite adequate medical and/or surgical treatment. The presence of CRSwNP in a patient with severe asthma should be considered as a treatable trait and as a predictor of therapeutic failure. Successful treatment of the symptoms inherent to CRSwNP will be reflected in the improvement of symptoms attributable to severe asthma. Despite less access, in Latin America biologics represent a therapeutic alternative reserved for those patients who are unable to control symptoms with standard treatment. </p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

¨The Importance of Diagnosing and Treating CRSwNP in Patients with Severe Asthma¨ Description of the Current Situation in Latin America

  • 期刊论文

  • 发表日期：

    2026年2月20日

查看全文
  • Nazareno Riolfi,
  • Jorge F. Máspero,
  • Mónica S. De Gennaro

摘要

Purpose of Review

to describe the positive impact of timely diagnosis and treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) on the symptoms of severe asthma in patients with both diseases in the context of Latin America based on available prevalence data in the region and to describe the diagnosis and treatment strategy currently employed.

Recent Findings

it is estimated that prevalence of CRSwNP in patients with severe asthma in Latin America is comparable to the data presented at global level. The impact on patients’ health is comparable to those patients with other chronic diseases with greater recognition (asthma, Typer 2 Diabetes, rheumatoid arthritis). Despite socioeconomic differences, the diagnosis and treatment strategies employed in these Latin American patients is comparable to those in Europe or the United States.

Summary

In Latin America it is estimated that the prevalence of patients with severe asthma and CRSwNP is comparable to the data presented globally. Patients with severe asthma and CRSwNP present a more severe disease with lower chances of therapeutic success despite adequate medical and/or surgical treatment. The presence of CRSwNP in a patient with severe asthma should be considered as a treatable trait and as a predictor of therapeutic failure. Successful treatment of the symptoms inherent to CRSwNP will be reflected in the improvement of symptoms attributable to severe asthma. Despite less access, in Latin America biologics represent a therapeutic alternative reserved for those patients who are unable to control symptoms with standard treatment.